Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Short Diagnosis to Treatment Interval Is Associated with Poor Outcomes in Relapse or Refractory Diffuse Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3090.

https://doi.org/10.1182/blood-2024-201328

Published: 2024

Journal Articles

Gnri (Geriatric Nutritional Risk Index) in Multiple Myeloma

Kohei Sato, Kazuhito Suzuki, Riku Nagao, Tadahiro Gunji, Masaharu Kawashima, Hideki Uryu, Mamiko Momoki, Hiroto Ishii, Mitsuji Katori, Susumu Tanoue, Atsushi Katsube, Hiroki Yokoyama, Takeshi Saito, Kaichi Nishiwaki, Shingo Yano

Blood (2024) 144 (Supplement 1): 1939.

https://doi.org/10.1182/blood-2024-203587

Published: 2024

Journal Articles

JALSG Ph (-) B-ALL213 Study: Pediatric-Type Chemotherapy Improves Prognosis in Adult Ph-Negative Acute Lymphoblastic Leukemia Patients, Including Older Adults

Blood (2024) 144 (Supplement 1): 2819.

https://doi.org/10.1182/blood-2024-199435

Published: 2024

Journal Articles

Low Immunoglobulin G and Low Lymphocyte-Monocyte Ratio at the End of Treatment Predict Early Progression in Diffuse Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 4459.

https://doi.org/10.1182/blood-2024-201850

Published: 2024

Journal Articles

The Area Under Tacrolimus Concentrations on Day 14-28 Is the Independent Predictor of the Development of Chronic Gvhd in Patients without Severe Acute Gvhd after Unrelated Allogeneic HSCT

Susumu Tanoue, Hiroki Yokoyama, Hiroto Ishii, Daiki Hattori, Iku Kamitani, Takeshi Saito, Shingo Yano

Blood (2023) 142 (Supplement 1): 2191.

https://doi.org/10.1182/blood-2023-180206

Published: 2023

Journal Articles

Geriatric Nutritional Risk Index Is an Important Predictor of Survival in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Iku Kamitani, Hiroki Yokoyama, Hiroto Ishii, Susumu Tanoue, Daiki Hattori, Takeshi Saito, Shingo Yano

Blood (2023) 142 (Supplement 1): 4968.

https://doi.org/10.1182/blood-2023-185882

Published: 2023

Journal Articles

Real-World Data in a Prospective Clinical Observation Study for Newly Diagnosed Adult Acute Lymphoblastic Leukemia, the JALSG ALL-CS-12 : Advanced Age Is a Poor Prognostic Factor

Yoshihiro Hatta, Fumihiko Hayakawa, Etsuko Yamazaki, Tohru Murayama, Takeshi Saito, Satoru Takada, Nobuaki Dobashi, Shuichi Ota, Yasuhisa Yokoyama, Masatsugu Tanaka, Shinya Sato, Shigeki Ohtake, Emiko Sakaida, Yoshinobu Maeda, Takahiro Yamauchi, Itaru Matsumura, Yasushi Miyazaki, Hitoshi Kiyoi

Blood (2023) 142 (Supplement 1): 4199.

https://doi.org/10.1182/blood-2023-178332

Published: 2023

Journal Articles

Clinical Significance of Reactivation of Salivary HHV-6 and HHV-7 in Multiple Myeloma Treated with Novel Agents

Kazuhito Suzuki, MD, Shingo Yano, MD, Nobuyuki Kobayashi, MD PhD, Yoji Ogasawara, MD, Takaki Shimada, MD, Katsuki Sugiyama, MD, Takeshi Saito, MD, Shinobu Takahara, MD, Kazuhiro Kondo, MD PhD, Hiroyuki Yanagisawa, MD PhD, Noriko Usui, MD, Keisuke Aiba, MD

Blood (2016) 128 (22): 5633.

https://doi.org/10.1182/blood.V128.22.5633.5633

Published: 2016

Journal Articles

A Retrospective Comparison of Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in Allogeneic Bone Marrow Transplantation from Unrelated Donors

Shingo Yano, Takeshi Saito, MD, Hiroki Yokoyama, MD, Tomohito Machishimia, MD, Takaki Shimada, MD, Yuichi Yahagi, MD PhD, Shinobu Takahara, MD, Yoji Ogasawara, MD PhD, Katsuki Sugiyama, MD, Jiro Minami, MD, Yutaro Kamiyama, MD, Atsushi Katsube, MD, Noriyuki Morikawa, MD, Kazuhito Suzuki, MD, Yumiko Inui, MD, Noriko Usui, Keisuke Aiba, MD, PhD

Blood (2014) 124 (21): 5867.

https://doi.org/10.1182/blood.V124.21.5867.5867

Published: 2014

Journal Articles

Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7–8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial

Takahiko Nakane, M.D., Ph.D., Hirohisa Nakamae, MD, PhD, Saiko Kurosawa, MD, Atsuo Okamura, MD, PhD, Michihiro Hidaka, MD, PhD, Takuya Yamashita, MD, PhD, Akio Kohno, MD, PhD, Takeshi Saito, MD, Yasutaka Aoyama, MD, PhD, Kazuo Hatanaka, MD, Yoshio Katayama, MD, PhD, Kimikazu Yakushijin, MD, PhD, Toshimitsu Matsui, MD, PhD, Akiyoshi Takami, MD, PhD, Takuhiro Yamaguchi, PhD, Masayuki Hino, MD, PhD, Takahiro Fukuda, MD

Blood (2013) 122 (21): 4586.

https://doi.org/10.1182/blood.V122.21.4586.4586

Published: 2013

Journal Articles

Standard Administration and Fractionated Administration of Gemtuzumab Ozogamicin for Patients with Relapsed and Refractory Acute Myeloid Leukemia

Yuichi Yahagi, MD, PhD, Noriko Usui, MD, Yuko Yamaguchi, MD, PhD, Nobuaki Dobashi, MD, Shingo Yano, MD, Yutaka Takei, MD, Katsuki Sugiyama, MD, Shinobu Takahara, MD, Yoji Ogasawara, MD, PhD, Takeshi Saito, MD, Kinuyo Kasama, MD, Hiroki Yokoyama, MD, Yutaro Kamiyama, MD, Atsushi Katsube, MD, Keisuke Aiba, MD, PhD

Blood (2012) 120 (21): 4342.

https://doi.org/10.1182/blood.V120.21.4342.4342

Published: 2012

Journal Articles

Pharmacokinetics for Once-Daily Modified Release Formulation Tacrolimus Hydrate in Unrelated Hematopoietic Stem Cell Transplantation.

Shingo Yano, MD, Shin-ichiro Mori, Takeshi Saito, MD, Hiroki Yokoyama, MD, Tomohito Machishima, Katsuki Sugiyama, MD, Yoji Ogasawara, MD, PhD, Kinuyo Kasama, MD, Noriko Usui, MD, Keisuke Aiba, MD, PhD, Takuya Yamashita, MD

Blood (2012) 120 (21): 3048.

https://doi.org/10.1182/blood.V120.21.3048.3048

Published: 2012

Journal Articles

Clinicopathological Features and Outcome of Der(1;7)(q10;p10) In Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Single-Center Analysis of Japanese Patients

Hiroki Yokoyama, MD, Noriko Usui, MD, Nobuaki Dobashi, MD, Shingo Yano, MD, Yuichi Yahagi, MD, PhD, Yutaka Takei, MD, Katsuki Sugiyama, MD, Yoji Ogasawara, MD, Shinobu Takahara, MD, Yuko Yamaguchi, MD, Takeshi Saito, MD, Takaki Shimada, MD, Fumi Mizorogi, MD, Ken Kaito, MD, Keisuke Aiba, MD

Blood (2010) 116 (21): 1878.

https://doi.org/10.1182/blood.V116.21.1878.1878

Published: 2010

Journal Articles

Role of Intensive Conditioning Regimens Followed by Allogeneic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Long-Term Follow-Up.

Jiro Minami, MD, Osamu Asai, MD, Nobuaki Dobashi, MD, Shingo Yano, MD, Hiroshi Osawa, MD, Yutaka Takei, MD, Yuichi Yahagi, MD, Shinobu Takahara, MD, Yoji Ogasawara, MD, Hiroko Otsubo, MD, Yuko Yamaguchi, MD, Takeshi Saito, MD, Dai Maruyama, MD, Tatsunosuke Kobayashi, MD, Yasutaka Hoshi, MD, Noriko Usui, MD

Blood (2006) 108 (11): 5358.

https://doi.org/10.1182/blood.V108.11.5358.5358

Published: 2006

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation after Combination Therapy with Imatinib and Intensive Chemotherapy for Newly Diagnosed Philadelphia Chromosome Positive (Ph + ) Acute Lymphoblastic Leukemia.

Noriko Usui, MD, Shingo Yano, MD, Shinobu Takahara, MD, Osamu Asai, MD, Nobuaki Dobashi, MD, Hiroshi Osawa, MD, Yutaka Takei, MD, Yoji Ogasawara, MD, Hiroko Otubo, MD, Yuko Yamaguchi, MD, Takeshi Saito, MD, Jiro Minami, MD, Ken Kaito, MD, Masayuki Kobayashi

Blood (2005) 106 (11): 5304.

https://doi.org/10.1182/blood.V106.11.5304.5304

Published: 2005

Journal Articles

Etoposide Containing Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia.

Takeshi Saito, Osamu Asai, Nobuaki Dobashi, Shingo Yano, Tamotsu Ichiba, Hiroshi Osawa, Yutaka Takei, Katuki Sugiyama, Yutaka Okawa, Sinobu Takahara, Yuko Yamaguchi, Jiro Minami, Noriko Usui, Masayuki Kobayashi

Blood (2004) 104 (11): 5034.

https://doi.org/10.1182/blood.V104.11.5034.5034

Published: 2004

Journal Articles

Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin

Yoshinobu Kanda, Shin Mineishi, Kunihisa Nakai, Takeshi Saito, Ryuji Tanosaki, Yoichi Takaue

Blood (2001) 97 (11): 3676–3677.

https://doi.org/10.1182/blood.V97.11.3676

Published: 2001

NARROW

Short Diagnosis to Treatment Interval Is Associated with Poor Outcomes in Relapse or Refractory Diffuse Large B-Cell Lymphoma

Gnri (Geriatric Nutritional Risk Index) in Multiple Myeloma

JALSG Ph (-) B-ALL213 Study: Pediatric-Type Chemotherapy Improves Prognosis in Adult Ph-Negative Acute Lymphoblastic Leukemia Patients, Including Older Adults

Low Immunoglobulin G and Low Lymphocyte-Monocyte Ratio at the End of Treatment Predict Early Progression in Diffuse Large B-Cell Lymphoma

The Area Under Tacrolimus Concentrations on Day 14-28 Is the Independent Predictor of the Development of Chronic Gvhd in Patients without Severe Acute Gvhd after Unrelated Allogeneic HSCT

Geriatric Nutritional Risk Index Is an Important Predictor of Survival in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Real-World Data in a Prospective Clinical Observation Study for Newly Diagnosed Adult Acute Lymphoblastic Leukemia, the JALSG ALL-CS-12 : Advanced Age Is a Poor Prognostic Factor

Clinical Significance of Reactivation of Salivary HHV-6 and HHV-7 in Multiple Myeloma Treated with Novel Agents

A Retrospective Comparison of Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in Allogeneic Bone Marrow Transplantation from Unrelated Donors

Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7–8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial

Standard Administration and Fractionated Administration of Gemtuzumab Ozogamicin for Patients with Relapsed and Refractory Acute Myeloid Leukemia

Pharmacokinetics for Once-Daily Modified Release Formulation Tacrolimus Hydrate in Unrelated Hematopoietic Stem Cell Transplantation.

Clinicopathological Features and Outcome of Der(1;7)(q10;p10) In Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Single-Center Analysis of Japanese Patients

Role of Intensive Conditioning Regimens Followed by Allogeneic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Long-Term Follow-Up.

Allogeneic Hematopoietic Stem Cell Transplantation after Combination Therapy with Imatinib and Intensive Chemotherapy for Newly Diagnosed Philadelphia Chromosome Positive (Ph + ) Acute Lymphoblastic Leukemia.

Etoposide Containing Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia.

Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only